Literature DB >> 7875259

Use of in vivo nasal transepithelial potential difference to evaluate efficacy in CF gene therapy phase I trials.

T C Chinet.   

Abstract

Mesh：

Year:  1994        PMID： 7875259

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

1.  Nasal potential difference in cystic fibrosis considering severe CFTR mutations.

Authors:  Ronny Tah Yen Ng; Fernando Augusto de Lima Marson; Jose Dirceu Ribeiro; Antonio Fernando Ribeiro; Carmen Silvia Bertuzzo; Maria Angela Gonçalves de Oliveira Ribeiro; Silvana Dalge Severino; Eulalia Sakano
Journal:  Dis Markers       Date:  2015-01-15       Impact factor: 3.434

2.  Synchronization modulation increases transepithelial potentials in MDCK monolayers through Na/K pumps.

Authors:  Vu Tran; Xiaodong Zhang; Lin Cao; Hanqing Li; Benjamin Lee; Michelle So; Yaohui Sun; Wei Chen; Min Zhao
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.